CDC25A and breast cancer: One of the compounds that has an inhibitory effect towards CDC25A/B is an o-hydroxybenzyl derivative RE44 (10d), which has shown promise in models of mouse tsFT210 breast cancer cell line in vivo (172, 173) (Table 2).